ClinicalTrials.gg
CompletedNCT06469177Updated Oct 29, 2026

Patient Centered Post-Op Pain Management Software Tool Interventional Study Verses Standard of Care

An interventional study of Pain Coach App in Post-operative Pain, Acute, Opioid Use, Unspecified and Arthroplasty Complications, sponsored by Nova Scotia Health Authority. Completed at 1 site in Canada. Open to participants aged 19 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-10-29.

Sponsored by Nova Scotia Health Authority · Not applicable, Interventional, and Treatment

How we know

Updated Oct 29, 2026Now CompletedPrimary completion moved+2 moreGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
87
Allocation
Randomized
Ages
19 Years and older
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 190 studies in Pain, Postoperative with a site in Canada — 38 open to participants now, 42 under way, 3 of them phase 3. Pain, Postoperative · Canada.

Enrollment
83rd of 175
87 · median 82
Started
2025
with 11 others
No phase
94 of 190
17 open now
Registered
175th of 190
by date
Lead sponsor
5 of 190
Nova Scotia Health Authority

Among the 190 studies in Pain, Postoperative with a site in Canada, this one is the 83rd largest by enrollment of the 175 interventional ones that give a count, is one of 12 that started in 2025, is one of 94 with no phase, and was the 175th registered.

Pain, Postoperative

5,675 studies on the registry are indexed under Pain, Postoperative; 1,243 are open to participants now.

Browse Pain, Postoperative studies →

Open to participants now

38 of the 190 studies in Pain, Postoperative with a site in Canada are open now. Recruiting first, the newest first:

33 more — sign in →

All 38 open studies →

A study can be open while its sites in Canada have not opened yet or have stopped. Only those recruiting at a site in Canada →

Who these studies take

Of the 678 Pain, Postoperative studies recruiting now, 239 (35%) set no upper age limit and 329 (49%) stop at 75 or younger; 74 take children under 18; 129 take healthy volunteers.

This study: 19 Years and older · all sexes · healthy volunteers too.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 190 studies in Pain, Postoperative with a site in Canada, or all of them as a file.
02

Study summary

The goal of this clinical trial is to learn if the Pain Coach App will result in less opioids being prescribed to and used by patients undergoing Shoulder/Hip/Knee Arthroplasty surgery while maintaining the same or better pain control versus standard of care. The main questions it aims to answer are:

  1. Will elective shoulder, hip and knee arthroplasty patients using PainCoach App be prescribed and/or use less opioids, measured by total morphine milliequivalents (MME) after surgery when compared to those treated as standard of care while maintaining similar pain control?
  2. Will arthroplasty surgeons using PainCoach App write more patient-specific prescriptions resulting in a reduction in opioids prescribed after surgery with no increase in further opioids prescribed in the months following surgery?
  3. Will the use of Pain Coach App lead to equal or reduced healthcare system utilization after surgery?
  4. Will patients and surgeons using PainCoach App find it helpful enough to use it again and recommend to colleagues, family and friends?

Researchers will compare participants assigned to use Pain Coach App vs participants assigned to standard of care arm to see if there are differences in opioid prescriptions and self reported use.

Participants will either use the Pain Coach App or follow standard of care instructions and be followed forward for the opioid prescriptions dispensed in community and self-reported opioids use at study end.

Read the detailed description

This will be a randomized, parallel group prospective interventional study. Patient participants will be consented and then randomized using a tool built into RedCap to either the "treatment group" and a "control group". The treatment group will be sent an email with instructions to set up a Pain Coach Account and download the app onto their mobile device. (Phone or tablet)The control group will not be offered Pain Coach technology and will just follow the usual care pathway for arthroplasty patients. When a participant in the treatment arm completes the initial questionnaire within the app (known as the Pain Coach Profile) this information will be used by a pharmacist in the study to create a suggested prescription for that patient. This suggested prescription will be provided to the patients surgeon for them to review and either accept, edit or discard based on their own clinical judgement.- For the rest of the study the patients in the treatment arm will have access to the Pain Coach app functionalities and use them as they require/prefer. A survey will be sent to both treatment and control groups after their surgery on Post Op Day 2 and 30 to assess pain control. There will be an interim analysis once 281 participants have been recruited into each treatment arm. At this point a retrospective chart review will be used to identify ED related visits for surgical pain within 90 days will be compared between groups at 6 months, also the amount of opioids prescribed (and number of refills) up to 3 months after surgery will be recorded and compared between groups. If at this point there is a statistically significant difference between groups the study will end early. Otherwise it will control until 561 participants are assigned to each group. This will provide 80% power to detect a minimally clinically important difference of 10% reduction in opioid prescribing between groups.

03

Conditions studied

  • Post-operative Pain, Acute
  • Opioid Use, Unspecified
  • Arthroplasty Complications
  • Knee Osteoarthritis
  • Shoulder Arthritis
  • Hip Arthritis
04

Who can participate

Ages eligible
19 Years and older
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Elective total shoulder (day surgery only), hip or knee arthroplasty completed within NSH, starting at the HI or DGH
  • OR date for surgery is known and booked
  • Able to access the internet via mobile device (has access to smart phone)
  • If expresses concern about low tech IQ, has a support person available
  • Able to read and write in English

Exclusion criteria

Exclusion Criteria:

  • Non-elective arthroplasty surgery procedures (trauma, fractures)
  • Bilateral knee or hip arthroplasty
  • Unable to read or write in English
  • Lacks capacity to provide consent due to cognitive impairment
  • No access to internet or mobile device to use self-help pain management tools
  • Inpatient Shoulder arthroplasty as residents write these discharge prescriptions
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
87 participants (actual)

Study arms

  • Experimental
    Pain Coach App Users

    Participants enrolled in Pain Coach App software and directed to download on their mobile device

    Device: Pain Coach App

  • No intervention
    Standard of Care

    Participants received traditional standard of care supports for joint arthroplasty surgery

Interventions

  • DevicePain Coach App

    Pain Coach App is a mobile application that offers patients undergoing shoulder, hip and knee arthroplasty surgery preoperative educational tools and questionnaires to provide patient specific details to their surgeons for prescribing purposes as well as post operative pain assessment and medication reminders/tracking, problem troubleshooting and a resource library for further pain management tools and education.

06

What researchers measure

Primary outcomes

  1. Opioid Prescriptions Efficacy Information

    Describe and compare immediate release opioids prescription quantities (in MME) filled by patients and surgeons using PainCoach App vs Standard of Care.

    Time frame: At discharge, 2 weeks, 1 and 3 months after surgery.

  2. Pain Related Adverse Effects

    Assess for any Pain/Opioid related side effects by administering the QoR-15 questionnaire (see appendix to both groups and reviewing ED visits by patients in both treatment and control groups to ensure safety/efficacy of application use.

    Time frame: Post Operative Day 2 and 30

Secondary outcomes

  1. Health Systems Usage

    Describe patient reported interactions with the healthcare system including patient reported calls to surgeon's office, calls to the Orthopedic Assessment Clinic, calls to their primary care provider and calls to their pharmacy as a composite endpoint

    Time frame: From discharge to 90 days post-op

  2. Self reported Opioid usage

    Describe and compare patients' self-reported usage of opioids after surgery. 1. How many days after surgery did they use opioids? 2. Did the patient use all of the opioids they were prescribed? (Yes/no) i. If no: How many opioid tablets did have left after surgery will be used to compare to amount originally filled to report absolute MME used after surgery for each treatment group.

    Time frame: At Post Op Day 30

  3. Surgeon Adoption

    Describe satisfaction and compliance with PainCoach App prescribing tools. 1. Were surgeons satisfied with the prescriptions and progress notes provided by PainCoach App? 2. Frequency surgeon followed one of three pathways: if they used the full suggested prescription, made changes or used their default prescribing pathway ? Which will be identified via chart review.

    Time frame: Study End

07

Study locations

1 site
  • Nova Scotia Health QEII and Dartmouth General Hospital
    Dartmouth, Nova Scotia B2T4G8, Canada
08

References and documents

Individual participant data

Plan to share: No

09

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedDate before it movedWhere the date was before it movedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Ran from Jan 2025 to primary completion in Mar 2026, 14 months.

Of 2,113 non-industry interventional studies with no phase under Pain, Postoperative, half reached primary completion within 11 months of starting (the median), counting those still running; a quarter within 6 and three quarters within 23. This study's 14 months is above that.

Counting every sponsor, half of 2,126 studies reached it within 11 months; a quarter within 6 and three quarters within 23.

Since we started tracking on Sep 25, 2026, the dates moved once, on Oct 29, 2026: primary completion Sep 2025 → Mar 2026 and completion Sep 2025 → May 2026.

Earlier changes are on the record history on ClinicalTrials.gov ↗

How these figures are worked out, and which studies are left out of them.

Registered
Jun 17, 2024
First posted
Jun 21, 2024
StartActual
Jan 7, 2025
Primary completionActual
Mar 26, 2026was Sep 2025
CompletionActual
May 28, 2026was Sep 2025
Last update
Oct 29, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Status
Enrolling by invitation→Completed
changed Oct 29, 2026
Primary completion
Sep 2025→Mar 26, 2026 (actual)
Oct 29, 2026
Study completion
Sep 2025→May 28, 2026 (actual)
Oct 29, 2026
Enrollment
1000 (estimated)→87 (actual)
Oct 29, 2026
Show all 1 update
  1. Oct 29, 2026
    Enrolling by invitation→Completed
    Primary completion Sep 2025→Mar 26, 2026 (now actual)
    Study completion Sep 2025→May 28, 2026 (now actual)
    Enrollment 1000 (estimated)→87 (actual)
    + 4 other changes: index terms, identifiers, verification date and oversight details

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT06469177
Responsible party
Sponsor
First posted
Jun 21, 2024
Start date
Jan 7, 2025
Primary completion
Mar 26, 2026
Completion
May 28, 2026
Last update
Oct 29, 2026

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Oct 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion